Type 2 diabetes can increase your risk of pancreatic cancer, but the amount of time since your diagnosis can affect your risk ...

Over a 10-year period, METS-IR effectively predicted CV events among patients with PsA, with values greater than 2.48 at baseline conferring the greatest risk.